Gilead Sciences Stock Analysis (NASDAQ:GILD)

Add to My Stocks
$68.83 $0.46 (0.66%) GILD stock closing price Feb 22, 2017 (Closing)
Watch Robo Advisor Video of GILD Stock Analysis
Gilead Sciences
Updated on : Feb 22, 2017
previous close
GILD 68.8 (0%)
S&P 500 2362.8 (0%)
Closing Price On: Feb 22, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
58%
Sector Average:
-1.1%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Compared to the industry
Dividend Yield
GILD dividend yield:
2.67%
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
PE Valuation
PS Valuation
Recent Growth
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
GILD PS :
3
Industry PS :
4.6
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
46.8%
Return on Equity:
78.5%
Double Tap To Exit Full Screen
0:00
/

Gilead Sciences Analysis Video

6589 9 2

View Gilead Sciences stock analysis video. This is our GILD analyst opinion covering the buy and sell arguments for GILD stock.

Gilead Sciences, Inc. Stock Rating (4.2/5)

Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy GILD stock?

  • The TTM operating margin was good at 58% for Gilead Sciences.
  • Net margins stood at a healthy 44.4% (average) for Gilead Sciences in the Trailing Twelve Months.
  • The price to earnings multiple of 6.1 is attractive when compared with the industry average PE ratio of 22.5.
  • GILD stock is trading at a favorable price to sales multiple of 3 as against the Medical-Biomed-Genetics industry average multiple of 4.6.
  • Gilead Sciences generates a high return on invested capital of 46.8%.
  • Gilead Sciences has a good Return On Equity (ROE) of 78.5%.

Should you sell GILD stock?

  • Gilead Sciences sales shrank by -13.9% year-over-year in 2016 Q4.

Comments on this video and Gilead Sciences stock